David S. Lowden Purchases 750 Shares of Diploma PLC (LON:DPLM) Stock

Posted by Scott Moore on Mar 24th, 2025

Diploma PLC (LON:DPLM – Get Free Report) insider David S. Lowden purchased 750 shares of the company’s stock in a transaction dated Friday, March 21st. The shares were bought at an average cost of GBX 3,928 ($50.72) per share, for a total transaction of £29,460 ($38,042.36).

Diploma Stock Performance

DPLM opened at GBX 3,934 ($50.80) on Monday. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. The company has a market cap of £5.25 billion, a price-to-earnings ratio of 45.22, a PEG ratio of 2.82 and a beta of 0.75. The company’s 50 day moving average is GBX 4,390.64 and its 200 day moving average is GBX 4,384.32. Diploma PLC has a 12-month low of GBX 3,372 ($43.54) and a 12-month high of GBX 4,808 ($62.09).

Diploma Increases Dividend

The company also recently declared a dividend, which was paid on Friday, January 31st. Shareholders of record on Thursday, January 16th were issued a dividend of GBX 42 ($0.54) per share. The ex-dividend date was Thursday, January 16th. This represents a yield of 0.93%. This is an increase from Diploma’s previous dividend of $17.30. Diploma’s payout ratio is currently 65.52%.

Analyst Upgrades and Downgrades

Separately, JPMorgan Chase & Co. raised their price objective on shares of Diploma from GBX 4,370 ($56.43) to GBX 4,420 ($57.08) and gave the stock a “neutral” rating in a report on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of GBX 4,567.50 ($58.98).

Check Out Our Latest Report on DPLM

About Diploma

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.